ClinicalTrials.gov
public full text
Public Domain
Evaluation of Brain Atrophy in CIS Patients on Avonex
The purpose of this study is * To examine if Avaonex can delay the development of clinically definite multiple sclerosis. * To investigate if Avonex can delay disability progression by slowing brain atrophy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)#1338066
- Disabilities and Health-Related Quality of Life in Multiple Sclerosis: Prospective 10-year Web-Based Study of a Population-Based Real-Life Cohort in the Netherlands.#1107728
- Canadian Avonex PEN Productivity Study#1060247
- COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS#882009
- Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.#1171454
Record · ID 1211023
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive